Please login to the form below
clinical trials
This page shows the latest clinical trials news and features for those working in and with pharma, biotech and healthcare.
Latest news
-
Duchenne UK backs Evox dystrophin delivery project
as well as experimental gene therapies that try to deliver a working dystrophin gene that are in clinical trials and gene-editing approaches such as CRISP/Cas9 that attempt to correct
-
Entering the era of digital trials
decades. Clinical trials performed before and after the adoption of electronic data capture (EDC) were the same in many key respects. ... Still bigger breakthroughs may come from technologies applied to the conduct of clinical trials.
-
MedCity sets up advanced therapy research network
London, Oxford and Cambridge, with speakers noting that the UK is a leader in ATMP clinical trials, recruiting more patients into studies than top US specialist centres such as Harvard and
-
The Final Frontier
What they really mean is that there’s no evidence for the use of medical cannabis in the way they would like to see the evidence: randomised- controlled trials, double-blind ... That is true. But it’s hard to conduct clinical trials on a therapeutic
-
Digital Trials
The recent Clinical Trials Transformation Initiative (CTTI) report recommended that a short feasibility study is carried out prior to implementation of the technology in a large study. ... As a consequence, clinical trials are changing. Digital
More from news
Approximately 163 fully matching, plus 1,110 partially matching documents found.
Latest Intelligence
-
Key considerations for disease- modifying Parkinson’s disease trials
Do not rely on biomarkers (such as pathological forms of α-Synuclein), but put clinical outcomes as an endpoint in phase 2 trials. ... Taking all these lessons learned into consideration should markedly lower the risk of a false negative result in
-
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
major advance in severe disease, despite some major bumps in the clinical development road and when big pharma companies got cold feet – and then finally proving its value to patients and ... and sustainable clinical pipeline and a robust product
-
Retaining reader value in plain language summaries of clinical studies
From 2019, sponsors of clinical research will need to prepare plain-language summaries (PLSs) for all phase 1-4 interventional trials, to fulfil requirements for greater transparency under EU Clinical Trials ... Practice makes perfect. For now, summaries
-
Tackling a formidable foe
Its trials demonstrated that patients achieved 50% fewer relapses and fewer new areas of MS activity and it currently has market authorisation in 39 countries. ... Working together. Hundreds of trials are bustling through clinical lines to decode the
-
Stakeholder dialogue in Europe’s adaptive pathways pilot
Evidence suggests that medicines using the resulting accelerated access initiatives experience variable reimbursement outcomes due to uncertainties in the clinical or economic evidence base. ... Efficacy and safety data from early compassionate use
More from intelligence
Approximately 9 fully matching, plus 140 partially matching documents found.
Latest appointments
-
Zelluna Immunotherapy appoints chief technology officer
His experience, acquired on both side’s of the Atlantic will provide invaluable for Zelluna in its immediate focus of delivering clinical proof of concept of its TCRs in adoptive cell ... He will play a big part in the execution of Zelluna’s
-
Neurocentrx appoints two members to the board
Brooksby said: “My focus is to accelerate the business model and drive commercial clinical trials to raise international awareness of what we are offering, and enter the global market.
-
Life Healthcare appoints two new starters
Joining Alisha is Caitlin McMaster (pictured right), who takes up an account executive role at Life Healthcare, working alongside the clinical trials team.
-
Topas Therapeutics appoints chief development officer and chief medical officer
Timm Jessen, chief executive officer, Topas, said: “Rupert has a long and successful track record of bringing drugs and biologics through clinical development and regulatory approval. ... At Topas, Dr. Sandbrink will guide projects into the clinic,
-
Belgium's TiGenix appoints Dr Gregory Gordon
Meanwhile, Valles-Sukkar arrives at TiGenix from Alexion Pharmaceuticals, where she was responsible for all aspects of clinical trial development. ... Annette has proven ability to manage large-scale late-stage clinical trials.”.
More from appointments
Approximately 0 fully matching, plus 61 partially matching documents found.
Latest from PMHub
-
Artificial Intelligence in Healthcare
Presently, the looming Brexit saga is casting shadows over the UK’ s ability to play host to clinical trials at the frontiers of medical innovation. ... But, with a joined-up digital healthcare system, robust clinical data sets, and the help of AI, why
-
Clinical Trials Market : Dynamics, Segments, Size and Demand, 2015 - 2025
These factors are expected to drive pressure on growth of clinical trials market. ... Clinical trials are conducted in four phases namely, Phase I, II, III and IV.
-
Unlocking potential: How can pharma capitalise on its resources to support the NHS?
However, now is the time to explore how pharma can share the huge range of valuable clinical information at its disposal in order to work more closely with the NHS and ... This content ranges from clinical evidence papers, to trials results reported in
-
New ICMJE Guidelines and their Impact on Biotech
crucial to securing the funding needed to initiate the pivotal trials required for product approval and, ultimately, a reliable revenue stream. ... Next year the situation may become more complicated for these companies because ICMJE is requiring that
-
Engaging patients in their clinical trial journey
Consequently, multimedia content in your patients’ own languages is a must for successful clinical trial communication. ... The same trends for engagement can be followed by those in the clinical trials industry when communicating with patients.
More from PMHub
Approximately 23 fully matching, plus 20 partially matching documents found.
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
Account Director
-
£48, 000 - £60, 000
-
Senior Medical Writer
-
Great salary and benefits
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Manager / Account Director
-
Competative
-
Associate Director
-
£75, 000-90, 000
- Senior Account Executive, London, Medical Communications
-
Excellent package
-
Senior Medical Writer
-
Competitive Salary
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
Subscribe to our email news alerts
- Oral Appliances lead Sleep Apnea Devices Market Growth, Shows Recent Analysis
- Animal Healthcare Market is poised to cross USD 36 billion by 2024
- Fishawack launches new website and introduces new structure for growth
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- Orphan drugs from Biogen and Amicus win UK Prix Galien
- AZ’s MYSTIC survival data is in – and it’s a bust
PMHub
Anatomy Health
We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
